A phase 1b, open label, multicenter study evaluating the safety and efficacy of ipatasertib in combination with rucaparib in patients with advanced breast, ovarian or prostate cancer [BO40933].

  • Pook, David (Primary Chief Investigator (PCI))
  • Baker, Emma (Project Manager)

Project: Research

StatusActive
Effective start/end date24/05/1931/12/24

Keywords

  • Medical Oncology
  • Cancer treatment
  • Clinical trial